HLA Hypersensitivity to Abacavir B5701 Test
Understanding HLA Hypersensitivity Testing for HIV Medication Safety
The HLA Hypersensitivity to Abacavir B5701 Test represents a groundbreaking advancement in personalized medicine for HIV treatment. This specialized genetic screening plays a critical role in preventing severe, potentially life-threatening hypersensitivity reactions in patients prescribed Abacavir, a cornerstone medication in modern HIV/AIDS therapy regimens.
What Does This Test Measure?
This sophisticated genetic analysis specifically detects the presence of the HLA-B*5701 allele, a genetic marker strongly associated with hypersensitivity reactions to Abacavir. The test utilizes cutting-edge PCR (Polymerase Chain Reaction) and sequencing technologies to provide accurate identification of this specific genetic variant.
- Detects HLA-B*5701 genetic variant
- Identifies predisposition to Abacavir hypersensitivity
- Uses advanced molecular diagnostic techniques
- Provides definitive genetic risk assessment
Who Should Consider This Test?
This essential screening is recommended for specific patient populations to ensure optimal medication safety and treatment outcomes.
Primary Candidates Include:
- Patients newly diagnosed with HIV/AIDS considering Abacavir-containing regimens
- Individuals scheduled to start Abacavir therapy for the first time
- Patients with family history of medication hypersensitivity reactions
- Individuals of specific ethnic backgrounds with higher HLA-B*5701 prevalence
- Patients experiencing unexplained symptoms while on Abacavir therapy
Clinical Importance and Benefits
The HLA Hypersensitivity to Abacavir B5701 Test offers numerous critical benefits for HIV patient care and medication management.
Key Advantages:
- Prevents Severe Reactions: Identifies patients at risk before starting treatment
- Personalized Treatment Planning: Enables customized HIV medication regimens
- Enhanced Patient Safety: Reduces risk of life-threatening hypersensitivity
- Cost-Effective Care: Prevents expensive emergency treatments and hospitalizations
- Peace of Mind: Provides confidence in medication safety for patients and providers
Understanding Your Test Results
Proper interpretation of HLA Hypersensitivity test results is essential for making informed treatment decisions.
Result Interpretation Guidelines:
- Positive Result: Indicates presence of HLA-B*5701 allele – Abacavir should be avoided
- Negative Result: No HLA-B*5701 detected – Abacavir can be considered with monitoring
- Clinical Correlation: Results should be interpreted by qualified healthcare providers
- Treatment Alternatives: Multiple effective HIV medications available for HLA-B*5701 positive patients
Test Pricing and Availability
| Test Description | Price |
|---|---|
| HLA Hypersensitivity to Abacavir B5701 Test – Discount Price | $200 USD |
| HLA Hypersensitivity to Abacavir B5701 Test – Regular Price | $300 USD |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities nationwide.
Take Control of Your HIV Treatment Safety
Don’t leave your medication safety to chance. The HLA Hypersensitivity to Abacavir B5701 Test provides essential genetic information that can prevent serious adverse reactions and ensure your HIV treatment journey remains safe and effective.
Ready to schedule your test? Contact our genetic counseling specialists today at +1(267) 388-9828 or book your appointment online. Our team is available to answer your questions and guide you through the testing process.
Note: Turnaround time for results is 10-12 days. Sample collection requires 4 mL (3 mL minimum) whole blood in Lavender Top EDTA tube, 6 mL (3 mL minimum) whole blood in Yellow Top ACD tube, or buccal swab collected in sterile container. No special preparation required.
